No Orkambi Deal Yet For England, But Vertex’ Portfolio Approach Still On The Table
Dialogue between Vertex and NHS England over cystic fibrosis drug Orkambi are set to continue after productive talks on April 25.
Dialogue between Vertex and NHS England over cystic fibrosis drug Orkambi are set to continue after productive talks on April 25.